Search results
Results from the WOW.Com Content Network
Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...
Retrieved from "https://en.wikipedia.org/w/index.php?title=Boston_Scientific_Corporation&oldid=19811070"
On December 5, 2005, Boston Scientific made a surprise unsolicited $24.6 billion bid to acquire Guidant, offering $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share. Guidant's stock price rose 10% on the news.
The first $50,000 capitalization for CPI was raised from a phone booth on the Minneapolis skyway system. [2] They began designing and testing their implantable cardiac pacemaker powered with a new longer-life lithium battery in 1971. The first heart patient to receive a CPI pacemaker emerged from surgery in June 1973.
Grover Cleveland "Cleve" Backster Jr. (February 27, 1924 – June 24, 2013) was an interrogation specialist for the Central Intelligence Agency (CIA), best known for his experiments with plants using a polygraph instrument in the 1960s which led to his theory of primary perception where he claimed that plants feel pain and have extrasensory perception (ESP), which was widely reported in the media.
In July 2007 the German public television channel SWR claimed that Beecher was involved with CIA studies on human drug experiments in the 1950s as a scientific expert, and may have contributed to the KUBARK Counterintelligence Interrogation document of 1963 based on his work in the United States and in secret CIA prisons in West-Germany. [10]
James Elmer Mitchell (born 1952) is an American psychologist and former member of the United States Air Force.From 2002, after his retirement from the military, to 2009, his company Mitchell Jessen and Associates received $81 million on contract from the CIA to carry out the torture of detainees, referred to as "enhanced interrogation techniques" that resulted in little credible information.
They borrowed $800,000 to start Boston Scientific, a manufacturer of medical devices. He helped grow the company through a series of astute acquisitions. [6] Nicholas was chief executive officer of the company until 1999, when he became chairman. He continued in that role until his retirement in 2016. [3]